MIRATI THERAPEUTICS INC (MRTX)

US60468T1051 - Common Stock

58.7  -0.1 (-0.17%)

After market: 58.99 +0.29 (+0.49%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
38.19M12.44M72.09M13.40M3.34M
Cost Of Goods
4.39M600.00KN/AN/AN/A
Gross Profit
33.80M11.84MN/AN/AN/A
Operating Expenses
798.67M771.43M645.27M382.76M225.44M
Research and Development
506.88M531.63M508.59M299.35M182.87M
Selling, General, and Administrative Expenses
291.80M239.80M136.68M83.41M42.57M
Operating Income
-764.86M-759.59M-573.18M-369.36M-222.10M
Interest Income/Expense
N/AN/A5.30M11.40M8.80M
Other Income/Expense
37.15M19.23M-5.30M30.00K50.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-725.62M-740.36M-578.49M-357.94M-213.26M
Income Tax
N/A510.00K3.30MN/AN/A
Net Income
-725.88M-740.87M-581.78M-357.94M-213.26M
EBITDA
-760.67M-756.66M-571.40M-368.72M-221.85M
 
Per Share Data
EPS Diluted Total Ops
-12.22-13.18-11.21-7.96-5.69
Non GAAP EPS
-12.22-13.18-11.17-7.95-5.64
 
Statistics
Gross Profit Margin
88.50%95.18%N/AN/AN/A
Profit Margin
-1900.71%-5955.55%-807.02%-2671.19%-6385.03%
Operating Profit Margin
-2002.78%-6106.03%-795.09%-2756.42%-6649.70%

All data in USD

Charts